Update to COVID-19 Molecular Diagnostics Specimen Requirements
![FDA maze of regulations](https://covid19briefings.com/wp-content/uploads/2020/05/AS_301344926-FDA-Blue-Maze-sm-1024x576.jpeg)
As the number of COVID-19 cases in the United States has increased, the availability of real COVID-19 positive specimens has also increased.
Questioning Appropriate SARS-CoV-2 Test Utilization (Part 2)
![Testing](https://covid19briefings.com/wp-content/uploads/2020/05/Testing-1024x726.png)
Mayo Clinic Laboratories is examining if utilization of SARS-CoV-2 serology testing may be optimized when coupled with PCR testing. Dr. Matthew J. Binnicker explains the lab test utilization strategy being evaluated to develop risk profiles and increase risk awareness.